Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Arbor announced the launch of Sotylize (sotalol HCl) oral solution for the treatment of life-threatening ventricular arrhythmias and for the maintenance of normal sinus rhythm in patients with highly symptomatic atrial fibrillation/atrial flutter. Sotylize is the first oral solution formulation of sotalol.
Sotalol, an antiarrhythmic, has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. Sotalol HCl consists of a racemic mixture of two isomers, both of which have similar Class III antiarrhythmic effects.
RELATED: Antiarrhythmic Agent Sotylize Gets FDA Approval
Sotylize oral solution is grape flavored and is available as a 5mg/mL strength in 250mL and 480mL bottles.
For more information call (866) 516-4950 or visit Sotylize.com.
